Skip to content

Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01048281
Enrollment
100
Registered
2010-01-13
Start date
2002-08-31
Completion date
2099-01-31
Last updated
2025-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Cancer, Gastric (Stomach) Cancer, Gastro-Esophageal(GE) Junction Cancer, Gastrointestinal Stromal Tumor (GIST), Stomach Cancer

Brief summary

Our research of the biology of upper gastrointestinal cancers involves the study of tissue samples and cells from biopsies of persons with gastric or esophageal cancer or blood samples from upper gastrointestinal cancer patients and persons at high inherited risk for these cancers. We hope to learn the role genes and proteins play in the development of gastric and esophageal cancer.

Interventions

PROCEDUREBlood draw
PROCEDURETissue tumor biopsy

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
Stanford University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Over 18 2. Diagnosed with gastric or esophageal cancer OR at an increased hereditary risk for upper GI cancer

Exclusion criteria

1. Under 18 2. No family or personal history of gastric or esophageal cancer

Design outcomes

Primary

MeasureTime frame
p53 activity by routine pathologic analysistime of collection
NER activity by routine pathologic analysistime of collection

Countries

United States

Contacts

Primary ContactMeredith Mills
bluett@stanford.edu(650) 724-5223

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026